Vaquphos 40.3% Injection
Marketer
Vaqure Remedies
Salt Composition
Sodium acid phosphate (40.3%)
Overview Vaquphos 40.3% Injection
Intravenous administration of 40.3% Vaquphos is indicated for managing hypercalcemia and hyperparathyroidism, as well as hypophosphatemia. Dosage and treatment length should strictly adhere to physician instructions. Prior to commencing therapy, any pre-existing allergies to this medication must be disclosed. Regular monitoring of calcium and phosphate levels will be conducted by your physician throughout treatment. Patients with a history of cardiac or renal disease should inform their doctor. Nausea and diarrhea are potential adverse effects.
Uses of Vaquphos 40.3% Injection
Elevated serum calcium | Overactive parathyroid glands
Major Benefits of Vaquphos 40.3% Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How to use Vaquphos 40.3% Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vaquphos 40.3% Injection works:
Vaquphos 40.3% Injection restores normal calcium levels by binding to and sequestering excess calcium ions.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vaquphos 40.3% Injection may pose safety risks; seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Vaquphos, at a concentration of 40.3%, is typically deemed safe for pregnant individuals. Preclinical trials using animal models have revealed minimal or absent negative impacts on fetal development; nevertheless, data from human clinical trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Vaquphos 40.3% Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant hazard.
DrivingSAFE
Driving ability is typically unaffected by Vaquphos 40.3% Injection.
KidneyCAUTION
Patients with kidney impairment should receive Vaquphos 40.3% Injection with careful monitoring. Dosage modification of Vaquphos 40.3% Injection may be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Vaquphos 40.3% Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Vaquphos 40.3% Injection :
NA
Facts to Know About Vaquphos 40.3% Injection
| Label | Value |
|---|---|
| Chemical Type | Phosphate Salts of Alkali Metals |
| Developing Habits | No. |
| Treatment Category | Essential Nutrients |
| Actions | Elevated Phosphate and Calcium |
3,018 People bought this recently